AMN, a rare disease, is characterized by dark reddish, wedge-shaped macular lesions.

The lipid-containing lubricating drop established noninferiority in comfort when compared to non-lipid drops, and the lipid-containing group also exhibited statistically significant improvements in visual quality at both day 7 and day 30, highlighting the potential benefits of this formulation for patients.

Increased choroidal thickness also was seen in children treated with 1% atropine for 1 week or 0.01% atropine for less than 8 weeks.

At the Tear Film and Ocular Surface meeting in Venice, Dr. Melissa Toyos shares findings on the mechanism of action of brimonidine tartrate.

Consumer inSights Q3 2024 shows shifts in eyewear spending: continuing preference for budget options, primarily in-store.

New research sheds light on how the dry eye medication lifitegrast works beyond the ocular surface, targeting the underlying immune system to provide relief for patients.

Dr. Shane Kannarr discusses findings on perfluorohexyloctane at the Tear Film and Ocular Surface conference, highlighting its rapid symptom relief and enhanced patient satisfaction.

Catch up on what happened in optometry during the week of October 28-November 1.

Comfort, vision, freedom from glasses, and convenience were cited as benefits of wearing contact lenses by survey participants.

Optical devices and rehabilitation training can improve a patient’s quality of life.

Dr. Walline shares his journey to the AAOpt presidency, his passion projects, and what’s to come at Academy 2024.

Six topics were assessed in the report, including global data on myopia prevalence, technology, environmental and genetic contributions to myopia onset and progression, and mechanistic causes of myopia pathogenesis, among others.

Higher prevalence rates were also found among university students and administrative workers.